Viking Healthcare Solutions
You’ve worked incredibly hard to demonstrate the clinical value (efficacy, safety, etc.) of your product for your FDA submission/approval. But can you demonstrate its value – clinical and financial – to the organizations (aka, payers, health insurers) who will be paying for your product, AND setting the parameters around patient access? Payers manage resource use by limiting access to products. Orphan/rare disease products are no exception..and are increasingly becoming targets for payer organizations. Do you know the avenues for negotiation around coverage and reimbursement? If not, you’ll need to. Knowing where your product stands in payers’ minds and developing your market access strategy at least 12-18 months leading up to product launch is crucial in today’s market. Having the right plan and team in place can make all the difference in the commercial success or struggle of your product.